Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder
Girolami, A.; Burul, A.; Cappellato, G.; Dal Bo Zanon, R.
Folia Haematologica 106(1): 65-71
1979
ISSN/ISBN: 0323-4347 PMID: 88391 Document Number: 140979
Factor IX antigen and activity were assayed in a group of patients with liver disease and in a group of patients in coumarin therapy. In patients with liver disease there was a similar decrease in activity and antigen. On the other hand factor IX activity is decreased in coumarin treatment with factor IX antigen remaining normal. Factor IX electrophoretic mobility in liver disease is normal.
Document emailed within 1 workday
Related Documents
Arkin, S.; Blei, F.; Fetten, J.; Foulke, R.; Gilchrist, G.S.; Heisel, M.A.; Key, N.; Kisker, C.T.; Kitchen, C.; Shafer, F.E.; Shah, P.C.; Strickland, D. 2000: Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(3): 255-259Violante, N.; Ciavarella, N. 1972: Blood coagulation disorder in a 7-year-old child with a partial factor X or Stuart-Prower factor deficiency Haematologica 58(9): 587-593
Kanjanapongkul, S. 2011: Report 2 cases of congenital factor XII deficiency: a rare coagulation disorder Journal of the Medical Association of Thailand 94 Suppl. 3: S231-S232
Suzuki, S. 1979: Studies on coagulation in newborn infants: liver maturation and vitamin K procoagulant-inhibitor relations Journal of Perinatal Medicine 7(4): 229-232
Benson, R.E.; Jones, D.W.; Dodds, W.J. 1983: Efficiency and precision of electroimmunoassay for canine factor VIII-related antigen American Journal of Veterinary Research 44(3): 399-403
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Hvas, A-Mette.; Buhl, H.; Laursen, N.Bech.; Hesse, B.; Berglund, L.; Nexo, E. 2006: The effect of recombinant human intrinsic factor on the uptake of vitamin B12 in patients with evident vitamin B12 deficiency Haematologica 91(6): 805-808
Ozturk, H.; Terzi, E.H.; Ozturk, H.; Kukner, A. 2008: The effects of N-acetylcysteine and vitamin C on liver and pulmonary tissue damage in rats following bile duct ligation Saudi Medical Journal 29(11): 1580-1584
Jin, Y.H.; Shen, X.L.; Wang, M.S.; Xu, X.M.; Liu, M.N.; Zhao, Z.S.; Zheng, J.Y. 2016: Association between the C46T polymorphism of coagulation factor Ⅻ gene and the involvement of factor Ⅻ activity in patients with unexplained recurrent spontaneous abortion Zhonghua Fu Chan Ke Za Zhi 51(8): 597-601
Aslanian, N.L.; Zalinian, L.S. 1973: Disorder of homeostasis of blood coagulation and fibrinolysis in patients with arterial hypotension Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny 13(6): 61-65
Suzuki, S. 1973: Changes brought about in blood coagulation in the newborn by administration of vitamin K2. I. Studies of the physiology of coagulation Zeitschrift für Kinderheilkunde 115(3): 245-254
Matsuda, M.; Wakabayashi, K.; Murayama, H. 1982: Vitamin K-dependent blood coagulation factors in surgical patients Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 45(4): 840-848
Coker, A.; Coker, I.; Huseyinov, A.; Sokmen, S.; Karademir, S. 2001: Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? Hepato-Gastroenterology 48(40): 1134-1137
Pryzjemski, J.; Wlasiuk, M.; Chrostowska, H. 1976: Assessment of the gluconeogenetic function of the liver on the basis of blood lactate elimination in patients with acute and chronic liver damage Przeglad Lekarski 33(12): 979-983
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Breithaupt, H. 1994: Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage Zeitschrift für Rheumatologie 53(4): 250-254
Ramirez, P.; Chavez, R.; Majado, M.; Munitiz, V.; Muñoz, A.; Hernandez, Q.; Palenciano, C.G.; Pino-Chavez, G.; Loba, M.; Minguela, A.; Yelamos, J.; Gago, M.R.; Vizcaino, A.S.; Asensi, H.; Cayuela, M.G.; Segura, B.; Marin, F.; Rubio, A.; Fuente, T.; Robles, R.; Bueno, F.S.; Sansano, T.; Acosta, F.; Rodriguez, J.M.; Navarro, F.; Cabezuelo, J.; Cozzi, E.; White, D.J.; Calne, R.Y.; Parrilla, P. 2000: Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days Transplantation 70(7): 989-998
Matsumoto, T.; Matsushita, S.; Okudaira, K.; Naruse, N.; Cho, T.; Muto, T.; Ashizawa, T.; Konuma, K.; Morita, N.; Ino, A. 2013: Risk and sex factor on suicide among substance use disorder patients Seishin Shinkeigaku Zasshi 115(7): 703-710
Matsumoto, T.; Matsushita, S.; Okudaira, K.; Naruse, N.; Cho, T.; Muto, T.; Ashizawa, T.; Konuma, K.; Morita, N.; Ino, A. 2013: Risk and sex factor on suicide among substance use disorder patients Seishin Shinkeigaku Zasshi 115(7): 703-710
Ueda, A.; Kusaba, T.; Yanase, T. 1983: Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus Clinical and Experimental Immunology 53(1): 217-224